Matches in Nanopublications for { ?s ?p "[The performance of miRNAs 21 and 221 in differentiating prostate cancer from nonmalignant cases was evaluated and compared to DRE and elevated PSA. miRNA 21 was overexpressed in 90�% of group A vs. 10�% of group B, while miRNA 221 was overexpressed in 80�% of group A vs. 20�% of group B (p?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP1217116.RAS947_slwc1BPU3uYN400zjuzDvVLxaGK64ZDrtfeiLI130_assertion description "[The performance of miRNAs 21 and 221 in differentiating prostate cancer from nonmalignant cases was evaluated and compared to DRE and elevated PSA. miRNA 21 was overexpressed in 90�% of group A vs. 10�% of group B, while miRNA 221 was overexpressed in 80�% of group A vs. 20�% of group B (p?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217116.RAS947_slwc1BPU3uYN400zjuzDvVLxaGK64ZDrtfeiLI130_provenance.
- NP1217118.RAic_2Zjd1dA6c2o6LyM7lUlxuYsypVek13GTcnYvsj6M130_assertion description "[The performance of miRNAs 21 and 221 in differentiating prostate cancer from nonmalignant cases was evaluated and compared to DRE and elevated PSA. miRNA 21 was overexpressed in 90�% of group A vs. 10�% of group B, while miRNA 221 was overexpressed in 80�% of group A vs. 20�% of group B (p?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217118.RAic_2Zjd1dA6c2o6LyM7lUlxuYsypVek13GTcnYvsj6M130_provenance.
- NP1217117.RAM0_i9P0Z8fdVtm0xAq4URpkVe7qdF0fCyKI3R9m43jE130_assertion description "[The performance of miRNAs 21 and 221 in differentiating prostate cancer from nonmalignant cases was evaluated and compared to DRE and elevated PSA. miRNA 21 was overexpressed in 90�% of group A vs. 10�% of group B, while miRNA 221 was overexpressed in 80�% of group A vs. 20�% of group B (p?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217117.RAM0_i9P0Z8fdVtm0xAq4URpkVe7qdF0fCyKI3R9m43jE130_provenance.
- NP1217120.RA3kUJUsjuLXGdkqS6zwj0MNwiWx0MQ_1qCMx7SmwLi0o130_assertion description "[The performance of miRNAs 21 and 221 in differentiating prostate cancer from nonmalignant cases was evaluated and compared to DRE and elevated PSA. miRNA 21 was overexpressed in 90�% of group A vs. 10�% of group B, while miRNA 221 was overexpressed in 80�% of group A vs. 20�% of group B (p?=?0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217120.RA3kUJUsjuLXGdkqS6zwj0MNwiWx0MQ_1qCMx7SmwLi0o130_provenance.